|
|
Volumn 29, Issue 6, 2015, Pages 1148-1155
|
|
Efficacy and safety of open-label ixekizumab treatment in Japanese patients with moderate-to-severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis
a
b
c
c
c
c
c
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIPSORIASIS AGENT;
CYCLOSPORIN;
ETRETINATE;
GAMMA GLUTAMYLTRANSFERASE;
IXEKIZUMAB;
METHOTREXATE;
PREDNISONE;
STEROID;
IMMUNOSUPPRESSIVE AGENT;
INTERLEUKIN 17;
MONOCLONAL ANTIBODY;
ADULT;
ARTICLE;
BODY SURFACE;
CARDIOVASCULAR DISEASE;
CORTICOSTEROID THERAPY;
CYTOPENIA;
DEPRESSION;
DERMATOLOGY LIFE QUALITY INDEX;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG FATALITY;
DRUG HYPERSENSITIVITY;
DRUG SAFETY;
DRUG WITHDRAWAL;
ECZEMA;
ERYTHRODERMIC PSORIASIS;
FEMALE;
GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL;
HUMAN;
INJECTION SITE REACTION;
INTERSTITIAL LUNG DISEASE;
JAPANESE (PEOPLE);
LACERATION;
LEUKOPENIA;
LIVER DISEASE;
MAINTENANCE DRUG DOSE;
MAJOR CLINICAL STUDY;
MALE;
MEDICAL PHOTOGRAPHY;
MULTICENTER STUDY;
NAIL PSORIASIS;
NEUTROPENIA;
OPEN STUDY;
PHASE 3 CLINICAL TRIAL;
PHOTOTHERAPY;
PNEUMOCYSTIS PNEUMONIA;
PRIORITY JOURNAL;
PSORIASIS SEVERITY INDEX;
PSORIASIS VULGARIS;
PUSTULAR PSORIASIS;
PUSTULE;
RHINOPHARYNGITIS;
SCALP PSORIASIS;
SEBORRHEIC DERMATITIS;
SKIN EDEMA;
SKIN PRURITUS;
STEROID THERAPY;
SYSTEMIC MYCOSIS;
SYSTEMIC THERAPY;
THROMBOCYTOPENIA;
TOPICAL TREATMENT;
TREATMENT DURATION;
TREATMENT RESPONSE;
TUBERCULOSIS;
VISUAL ANALOG SCALE;
ANTAGONISTS AND INHIBITORS;
CLINICAL TRIAL;
JAPAN;
MIDDLE AGED;
PATHOLOGY;
PSORIASIS;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
ADULT;
ANTIBODIES, MONOCLONAL, HUMANIZED;
FEMALE;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
INTERLEUKIN-17;
JAPAN;
MALE;
MIDDLE AGED;
PSORIASIS;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
|
|
EID: 84929630475
PISSN: 09269959
EISSN: 14683083
Source Type: Journal
DOI: 10.1111/jdv.12773 Document Type: Article |
|
Times cited : (108)
|
|
References (15)
|
